PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements
- PMID: 15942942
- DOI: 10.1002/gcc.20214
PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements
Abstract
We present an extensive characterization of 10 B-cell lymphomas with a t(9;14)(p13;q32). The presence of the PAX5/IGH gene rearrangement was demonstrated by fluorescence in situ hybridization (FISH) using a validated probe set, whereas complex karyotypic changes were reassessed by multiplex-FISH (M-FISH). Pathologic and clinical review revealed the presence of this rearrangement in 4 histiocyte-rich, T-cell-rich B-cell lymphomas (HRTR-BCLs) and 2 posttransplantation diffuse large B-cell lymphomas (PTLD-DLBCLs). In contrast to initial observations describing this translocation in lymphoplasmacytic lymphoma (LPL) and LPL-derived large B-cell lymphoma, our data showed a wide morphologic and clinical spectrum associated with the PAX5/IGH rearrangement, pointing to an association between this aberration and a subset of de novo DLBCLs presenting with advanced disease and adverse prognosis. In addition, the recurrent incidence of this rearrangement in both HRTR-BCL (4 cases) and PTLD-DLBCL (2 cases) was previously unrecognized and is intriguing.
Similar articles
-
Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.J Mol Diagn. 2005 Aug;7(3):346-51. doi: 10.1016/S1525-1578(10)60563-6. J Mol Diagn. 2005. PMID: 16049306 Free PMC article.
-
Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.Anticancer Res. 2005 Sep-Oct;25(5):3179-82. Anticancer Res. 2005. PMID: 16101124
-
Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).Hum Pathol. 2004 Apr;35(4):447-54. doi: 10.1016/j.humpath.2003.10.014. Hum Pathol. 2004. PMID: 15116325
-
Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).Leuk Lymphoma. 1999 Jun;34(1-2):25-33. doi: 10.3109/10428199909083377. Leuk Lymphoma. 1999. PMID: 10350329 Review.
-
The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.Leuk Lymphoma. 2000 Feb;36(5-6):435-45. doi: 10.3109/10428190009148390. Leuk Lymphoma. 2000. PMID: 10784387 Review.
Cited by
-
t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.J Clin Exp Hematop. 2021 Dec 22;61(4):216-220. doi: 10.3960/jslrt.21025. Epub 2021 Oct 26. J Clin Exp Hematop. 2021. PMID: 34707037 Free PMC article.
-
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.Blood. 2011 May 5;117(18):4726-35. doi: 10.1182/blood-2010-12-323238. Epub 2011 Mar 8. Blood. 2011. PMID: 21385849 Free PMC article.
-
EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms.Front Immunol. 2024 Jan 22;15:1320689. doi: 10.3389/fimmu.2024.1320689. eCollection 2024. Front Immunol. 2024. PMID: 38318177 Free PMC article. Review.
-
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.Mod Pathol. 2010 Apr;23(4):593-602. doi: 10.1038/modpathol.2010.4. Epub 2010 Jan 29. Mod Pathol. 2010. PMID: 20118907 Free PMC article.
-
Molecular Update and Evolving Classification of Large B-Cell Lymphoma.Cancers (Basel). 2021 Jul 3;13(13):3352. doi: 10.3390/cancers13133352. Cancers (Basel). 2021. PMID: 34283060 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources